Question 10 of 20 Intermediate Concept

What is cellular senescence, and how would you show a cell is senescent?

Short answer

Senescence is a stable arrest of the cell cycle in a cell that stays alive and metabolically active, usually driven through p53 and p21 or through p16, and often accompanied by a secretory phenotype. No single marker proves it, so it is shown by combining durable arrest, cell cycle inhibitor expression, absence of death and a secretory signature.

Why

Many stresses trigger it: telomere shortening, DNA damage, oncogene activation and oxidative stress. The 2025 review by Ajoolabady and colleagues describes these converging on p53 with the cyclin-dependent kinase inhibitors p21 and p16, which block cyclin-dependent kinase and cyclin complexes and arrest the cycle. The senescence-associated secretory phenotype adds cytokines, chemokines, proteases and growth factors, which can remodel tissue, recruit immune cells and in some settings promote tumor growth.

Detection is awkward because every individual marker is shared with something else. Senescence-associated beta-galactosidase staining also appears in confluent or lysosome-rich cells. p16 rises in some senescent cells and not others, and varies by cell type. Absence of proliferation alone could be quiescence, which is reversible, so a serum or mitogen challenge that fails to restart division is informative.

The practical answer is a panel: no EdU or BrdU incorporation over days, raised p21 or p16, enlarged flattened morphology, secretory markers, and the absence of apoptosis markers. State which markers were used, because results in this field do not transfer between cell types.

A strong answer covers

Stable arrest in a living, active cell
p53 with p21, and p16, as the main routes
Secretory phenotype as a functional feature
No single marker is sufficient
Challenge with mitogens to exclude reversible quiescence

Common mistakes

Using beta-galactosidase staining alone as proof of senescence
Confusing quiescence with senescence because both are non-dividing
Assuming the same marker panel works across cell types

The interviewer might ask next

How would you test whether a treatment induces senescence rather than simply slowing growth?